Indeed, some preclinical studies have reported synergism between the autophagy inhibitors chloroquine or hydroxychloroquine and EGFR TKIs in NSCLC, breast cancer, and glioblastoma55,56,64,65. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.